HIV Infections
Showing NaN - NaN of 560
Vulnerable Youth With Limited Interaction and Digital Health
Recruiting
- HIV Infections
- Sexual Behavior
- Keeping it LITE
-
Chicago, IllinoisJohn H. Stroger, Jr. Hospital of Cook County
Apr 27, 2023
HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))
Recruiting
- HIV Infections
- Oral Cabotegravir (CAB)
- +4 more
-
La Jolla, California
- +30 more
Feb 2, 2023
Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)
Recruiting
- Hepatitis B
- HIV Infections
- Selgantolimod
- Placebo
-
San Diego, California
- +35 more
Jan 31, 2023
HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)
Active, not recruiting
- HIV Infections
- Cabotegravir Tablets
- +4 more
-
Bakersfield, California
- +116 more
Jan 22, 2023
Transgenderism, HIV Trial in Chicago (Transgender men's perspectives on HIV risk and HIV prevention interventions)
Recruiting
- Transgenderism
- HIV Infections
- Transgender men's perspectives on HIV risk and HIV prevention interventions
-
Chicago, IllinoisInstitute for Sexual and Gender Minority Health and Wellbeing
Dec 16, 2022
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
- HIV Infections
-
Los Angeles, California
- +62 more
Dec 7, 2022
Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)
Completed
- Lipodystrophy
- HIV Infections
- Tesamorelin
- Placebo for Tesamorelin
-
Birmingham, Alabama
- +46 more
Sep 16, 2022
HIV Trial in Chicago, New York (mLab App, HIV Prevention Information, HIV Home Tests)
Active, not recruiting
- HIV Infections
- mLab App
- +2 more
-
Chicago, Illinois
- +1 more
Sep 21, 2022
Antiretroviral Drugs and Related Drugs During and After
HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))
Completed
- HIV Infections
- DTG + 3TC
- TAF based regimen (TBR)
-
Phoenix, Arizona
- +132 more
Jun 27, 2022
HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)
Recruiting
- HIV Infections
- +2 more
- Letermovir 240 MG Oral Tablet
- +2 more
-
Birmingham, Alabama
- +18 more
Jun 20, 2022
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK1349572
- +3 more
-
Birmingham, Alabama
- +180 more
Mar 14, 2022
HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)
Recruiting
- HIV Infections
- Doravirine 100 Mg
- +5 more
-
Birmingham, Alabama
- +22 more
Feb 22, 2022
HIV Trial in United States (Cabotegravir (CAB) tablet, CAB LA, Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) tablet)
Active, not recruiting
- HIV Infections
- Cabotegravir (CAB) tablet
- +2 more
-
Aurora, Colorado
- +3 more
Feb 17, 2022
HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)
HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))
Completed
- HIV Infections
- Tuberculosis
- Levonorgestrel (LNG)
-
Chicago, Illinois
- +17 more
Dec 22, 2021
HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)
Recruiting
- HIV Infections
- Standard of Care (SOC) Oral ART
- +6 more
-
Birmingham, Alabama
- +34 more
Dec 1, 2021
HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) monovalent vaccine)
Completed
- HIV Infections
- H1N1 Influenza Virus
- Influenza A (H1N1) monovalent vaccine
-
Alhambra, California
- +30 more
Nov 3, 2021
HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) 2009 monovalent vaccine)
Completed
- HIV Infections
- H1N1 Influenza Virus
- Influenza A (H1N1) 2009 monovalent vaccine
-
Birmingham, Alabama
- +36 more
Nov 3, 2021
HIV Trial in Worldwide (Recombinant interleukin-2 (rIL-2))
Completed
- HIV Infections
- Recombinant interleukin-2 (rIL-2)
-
Los Angeles, California
- +247 more
Nov 2, 2021